Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

Clinical trial NCT07645625 · RECRUITING

Trial details

NCT number: NCT07645625
Sponsor: University Medical Center Groningen
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2026-05-11
Primary completion: 2030-05-01
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.